BioSpace News Archive

BioCapital

Research Roundup: COVID-19 Neurological Damage and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

October 15, 2020
·
5 min read
·
Mark Terry
Deals

Eli Lilly Acquires Disarm Therapeutics in an Effort to Solve Axonal Degeneration

Eli Lilly is betting on a new approach to axonal degeneration, announcing a definitive agreement to acquire Disarm Therapeutics, a privately-held biotech company committed to solving this mystery.

October 15, 2020
·
2 min read
·
Heather McKenzie
Diabetic Ulcers Treatment Market is Expected to reach US$ 13 bn by 2026

The global diabetic ulcers treatment market was valued at approximately US$ 7.3 Bn in 2017 and is anticipated to reach a value of approximately US$ 13.6 Bn by 2026, expanding at a CAGR of over 7.0% from 2018 to 2026.

October 15, 2020
·
5 min read
Health Insurance Exchange Market |North America and Europe are currently global leaders in the Market

A market for various insurance offerings to be pooled and presented to the public for possible cover against illnesses, health insurance exchange is a crucial enabler of better healthcare outcomes.

October 15, 2020
·
4 min read
Emergency medical services (EMS) estimated to Expand at a Higher CAGR During the Forecast Period

The rise in the number of emergency cases such as heart attack and trauma-related attacks is estimated to be a significant factor for the growth of the intraosseous devices market during the forecast period of 2018-2026.

October 15, 2020
·
8 min read
Molecular Biology Enzymes and Kits & Reagents Market Detailed Analysis and Forecast by 2029

The drive for molecular biology enzymes, kits and reagents, stems from steady strides being made in life sciences industry.

October 15, 2020
·
3 min read
Retinal Implant Market: Current Trends and Growth Opportunities

Retinal implants are biomedical microchips designed to provide visual perception to people who have lost vision owing to degenerative eye diseases such as retinitis pigmentosa and age-related macular degeneration.

October 15, 2020
·
5 min read
Transgene and BioInvent to Present Data on Oncolytic Virus BT-001 at the SITC 35th Anniversary Annual Meeting

Transgene, and BioInvent International AB announce that they will be presenting a poster on BT-001 at the Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting.

October 15, 2020
·
5 min read
Business

Emergent BioSolutions to Release Third Quarter 2020 Financial Results and Conduct Conference Call on November 5, 2020

Emergent BioSolutions Inc. will host a conference call on Thursday, November 5, 2020 at 5:00 pm to discuss the financial results for the third quarter of 2020, recent business developments, revenue guidance for the fourth quarter of 2020, and financial outlook for full year 2020.

October 15, 2020
·
1 min read
Drug Development

New First-in-Class Phase 3 Data Demonstrate TREMFYA® (guselkumab) Maintained Skin Clearance Rates Through Nearly 5 Years of Continuous Use in Adult Patients with Moderate to Severe Plaque Psoriasis

Data from VOYAGE 1 open-label, long-term extension study show sustained efficacy response rates at week 252 and no new safety signals

October 15, 2020
·
13 min read